Literature DB >> 24037532

Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease.

D R Cook1, K L Rossman2, C J Der3.   

Abstract

The aberrant activity of Ras homologous (Rho) family small GTPases (20 human members) has been implicated in cancer and other human diseases. However, in contrast to the direct mutational activation of Ras found in cancer and developmental disorders, Rho GTPases are activated most commonly in disease by indirect mechanisms. One prevalent mechanism involves aberrant Rho activation via the deregulated expression and/or activity of Rho family guanine nucleotide exchange factors (RhoGEFs). RhoGEFs promote formation of the active GTP-bound state of Rho GTPases. The largest family of RhoGEFs is comprised of the Dbl family RhoGEFs with 70 human members. The multitude of RhoGEFs that activate a single Rho GTPase reflects the very specific role of each RhoGEF in controlling distinct signaling mechanisms involved in Rho activation. In this review, we summarize the role of Dbl RhoGEFs in development and disease, with a focus on Ect2 (epithelial cell transforming squence 2), Tiam1 (T-cell lymphoma invasion and metastasis 1), Vav and P-Rex1/2 (PtdIns(3,4,5)P3 (phosphatidylinositol (3,4,5)-triphosphate)-dependent Rac exchanger).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24037532      PMCID: PMC4875565          DOI: 10.1038/onc.2013.362

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  225 in total

1.  CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration.

Authors:  L Y Bourguignon; H Zhu; L Shao; Y W Chen
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

2.  Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response.

Authors:  Anatoly Rubtsov; Pamela Strauch; Alyssa Digiacomo; Jiancheng Hu; Roberta Pelanda; Raul M Torres
Journal:  Immunity       Date:  2005-11       Impact factor: 31.745

3.  S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells.

Authors:  W D Hardt; L M Chen; K E Schuebel; X R Bustelo; J E Galán
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

4.  Mutation in Sos1 dominantly enhances a weak allele of the EGFR, demonstrating a requirement for Sos1 in EGFR signaling and development.

Authors:  D Z Wang; V E Hammond; H E Abud; I Bertoncello; J W McAvoy; D D Bowtell
Journal:  Genes Dev       Date:  1997-02-01       Impact factor: 11.361

5.  Structural basis for the reversible activation of a Rho protein by the bacterial toxin SopE.

Authors:  Gretel Buchwald; Andrea Friebel; Jorge E Galán; Wolf-Dietrich Hardt; Alfred Wittinghofer; Klaus Scheffzek
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

6.  A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation.

Authors:  Vera M Kalscheuer; Luciana Musante; Cheng Fang; Kirsten Hoffmann; Celine Fuchs; Eloisa Carta; Emma Deas; Kanamarlapudi Venkateswarlu; Corinna Menzel; Reinhard Ullmann; Niels Tommerup; Leda Dalprà; Andreas Tzschach; Angelo Selicorni; Bernhard Lüscher; Hans-Hilger Ropers; Kirsten Harvey; Robert J Harvey
Journal:  Hum Mutat       Date:  2009-01       Impact factor: 4.878

7.  Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function.

Authors:  Harrison J Hocker; Kwang-Jin Cho; Chung-Ying K Chen; Nandini Rambahal; Sreenivasa Rao Sagineedu; Khozirah Shaari; Johnson Stanslas; John F Hancock; Alemayehu A Gorfe
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-04       Impact factor: 11.205

8.  FGD1 as a central regulator of extracellular matrix remodelling--lessons from faciogenital dysplasia.

Authors:  Elisabeth Genot; Thomas Daubon; Vincenzo Sorrentino; Roberto Buccione
Journal:  J Cell Sci       Date:  2012-08-01       Impact factor: 5.285

9.  Kalirin-7 is required for synaptic structure and function.

Authors:  Xin-Ming Ma; Drew D Kiraly; Eric D Gaier; Yanping Wang; Eun-Ji Kim; Eric S Levine; Betty A Eipper; Richard E Mains
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

10.  Epithelial cell transforming sequence 2 in human oral cancer.

Authors:  Manabu Iyoda; Atsushi Kasamatsu; Takashi Ishigami; Dai Nakashima; Yosuke Endo-Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

View more
  170 in total

Review 1.  Janus-faces of NME-oncoprotein interactions.

Authors:  Nikolina Vlatković; Shie-Hong Chang; Mark T Boyd
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-01       Impact factor: 3.000

Review 2.  Targeting Rac and Cdc42 GTPases in Cancer.

Authors:  María Del Mar Maldonado; Suranganie Dharmawardhane
Journal:  Cancer Res       Date:  2018-06-01       Impact factor: 12.701

Review 3.  Inhibition of Cdc42 and Rac1 activities in pheochromocytoma, the adrenal medulla tumor.

Authors:  Pauline Croisé; Laurent Brunaud; Petra Tóth; Stéphane Gasman; Stéphane Ory
Journal:  Small GTPases       Date:  2016-06-29

4.  Fine-Tuning of the Actin Cytoskeleton and Cell Adhesion During Drosophila Development by the Unconventional Guanine Nucleotide Exchange Factors Myoblast City and Sponge.

Authors:  Bridget Biersmith; Zong-Heng Wang; Erika R Geisbrecht
Journal:  Genetics       Date:  2015-04-23       Impact factor: 4.562

5.  A Nonpump Function of Sodium Iodide Symporter in Thyroid Cancer via Cross-talk with PTEN Signaling.

Authors:  Fang Feng; Lamis Yehia; Ying Ni; Yi Seok Chang; Sissy Meihua Jhiang; Charis Eng
Journal:  Cancer Res       Date:  2018-09-14       Impact factor: 12.701

6.  DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.

Authors:  Jonathan F Goodwin; Vishal Kothari; Justin M Drake; Shuang Zhao; Emanuela Dylgjeri; Jeffry L Dean; Matthew J Schiewer; Christopher McNair; Jennifer K Jones; Alvaro Aytes; Michael S Magee; Adam E Snook; Ziqi Zhu; Robert B Den; Ruth C Birbe; Leonard G Gomella; Nicholas A Graham; Ajay A Vashisht; James A Wohlschlegel; Thomas G Graeber; R Jeffrey Karnes; Mandeep Takhar; Elai Davicioni; Scott A Tomlins; Cory Abate-Shen; Nima Sharifi; Owen N Witte; Felix Y Feng; Karen E Knudsen
Journal:  Cancer Cell       Date:  2015-07-13       Impact factor: 31.743

Review 7.  Establishment of epithelial polarity--GEF who's minding the GAP?

Authors:  Siu P Ngok; Wan-Hsin Lin; Panos Z Anastasiadis
Journal:  J Cell Sci       Date:  2014-07-02       Impact factor: 5.285

8.  The first DEP domain of the RhoGEF P-Rex1 autoinhibits activity and contributes to membrane binding.

Authors:  Sandeep K Ravala; Jesse B Hopkins; Caroline B Plescia; Samantha R Allgood; Madison A Kane; Jennifer N Cash; Robert V Stahelin; John J G Tesmer
Journal:  J Biol Chem       Date:  2020-07-13       Impact factor: 5.157

9.  Overexpression of GEFT, a Rho family guanine nucleotide exchange factor, predicts poor prognosis in patients with rhabdomyosarcoma.

Authors:  Chao Sun; Chunxia Liu; Shugang Li; Hongan Li; Yuanyuan Wang; Yuwen Xie; Bingcheng Li; Xiaobin Cui; Yunzhao Chen; Wenjie Zhang; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 10.  Rho GTPases: Regulation and roles in cancer cell biology.

Authors:  Raquel B Haga; Anne J Ridley
Journal:  Small GTPases       Date:  2016-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.